Blue Sky Scrubs Celebrates World Oceans Day with Commitment to Sustainability and Ocean Conservation

“Blue Sky Scrubs Sells Environmentally Friendly Scrub Caps and Scrubs For Health Care Providers.”

Austin, TX – June 5, 2025 – In recognition of World Oceans Day, Blue Sky Scrubs, a pioneer in premium medical apparel, proudly joins the global call to protect and restore the health of our oceans. Since its founding in 2005, Blue Sky Scrubs has embraced environmentally responsible practices — and on this special day, the company reaffirms its mission to support a cleaner, healthier, and more sustainable future for our planet.

World Oceans Day, officially recognized by the United Nations, is celebrated every year on June 8. It serves as a rallying point for individuals, businesses, and governments to take concrete action toward safeguarding the oceans that sustain all life on Earth. This year’s theme, “Catalyzing Action for Our Ocean & Climate”, urges communities worldwide to unite around the urgent need to protect marine ecosystems and address climate change.

“Oceans cover over 70% of the Earth’s surface and produce more than half the oxygen we breathe,” says Stephanie Beard, Founder and CEO of Blue Sky Scrubs. “As a company deeply committed to sustainability and wellness, we believe our responsibility doesn’t end with great scrubs — it extends to the planet we all share.”

A Brand Born with Purpose

Since day one, Blue Sky Scrubs has built its brand on values of quality, integrity, and environmental stewardship. Long before sustainability became a trend, the company implemented eco-conscious choices in its supply chain, packaging, and product development.

  • Minimal Waste Production – Blue Sky Scrubs follows lean manufacturing principles to reduce textile waste during production. Patterns are optimized to use as much fabric as possible, and leftover material is repurposed or recycled wherever feasible.

  • Eco-Friendly Packaging – Orders are shipped in recyclable materials with minimal plastic usage, and efforts are made to reduce shipping emissions by using consolidated delivery methods.

  • Durable, Long-Lasting Apparel – By designing scrubs that are built to last, Blue Sky encourages reduced consumer waste. High-quality materials and classic styles extend the life cycle of each garment.

“Sustainability is not a marketing strategy for us — it’s part of our DNA,” adds Beard. “We’ve been designing with the Earth in mind since our very first stitch.”

The Oceans Are in Crisis

The world’s oceans are facing unprecedented threats. From plastic pollution and overfishing to coral bleaching and rising sea levels, the health of our marine ecosystems is rapidly declining. According to the UN, 8 million tons of plastic end up in the ocean every year, and nearly one-third of fish stocks are overexploited.

Climate change has further compounded the crisis, causing ocean temperatures to rise, altering marine food chains, and intensifying the frequency of extreme weather events.

“Healthy oceans are vital to life, but they are not invincible,” says marine ecologist Dr. Rachel Lam, a World Oceans Day ambassador. “We need urgent, coordinated action across all sectors — from individuals and communities to corporations and policymakers.”

Blue Sky’s Oceans Day Action Plan

To celebrate World Oceans Day 2025, Blue Sky Scrubs is launching a weeklong campaign, “Scrub the Ocean Clean”, from June 8–15. During this campaign:

  • 10% of all profits will be donated to ocean conservation organizations, including:

    • The Ocean Cleanup, focused on removing plastic from oceans and rivers

    • Surfrider Foundation, dedicated to protecting clean water and coastlines

    • Oceana, working to restore biodiversity through policy reform

  • Blue Sky will host an internal Plastic-Free Challenge, encouraging employees and customers to reduce single-use plastic use in their daily lives. Participants will receive a digital sustainability toolkit and be entered into a giveaway for eco-conscious gear.

  • The company will also publish an educational blog series throughout the week, spotlighting ocean conservation heroes, sustainable living tips, and the connection between climate change and public health.

“As a company rooted in the healthcare industry, we see ocean health as a human health issue,” says Beard. “Whether it’s the food we eat, the air we breathe, or the communities we serve, everything is connected.”

Looking Ahead: A Greener Future for Medical Apparel

Blue Sky Scrubs is also exploring new ways to make its products even more eco-friendly. The company is currently investing in research and development of sustainable fabric blends, including those made from recycled ocean plastic and regenerative organic cotton.

Additionally, the brand is piloting a scrub recycling program, where customers can return their worn-out garments for responsible disposal or reuse — a step toward closing the loop and reducing medical apparel waste.

“We’re not perfect, but we’re always striving to do better,” Beard says. “If we can inspire our customers — many of whom are doctors, nurses, and caregivers — to care more deeply about the planet, then we’ve succeeded.”

A Call to Action

World Oceans Day is not just about raising awareness; it’s about driving action. Blue Sky Scrubs invites its customers, partners, and community to become part of the solution. Small actions — like skipping plastic bags, choosing sustainable brands, or learning about ocean conservation — add up to big impacts.

Together, we can create a future where our oceans are vibrant, resilient, and thriving.

“Every decision we make — as consumers, as companies, as citizens — matters,” Beard concludes. “We’re proud to be part of a global movement to protect the blue heart of our planet.”

About Blue Sky Scrubs

Blue Sky Scrubs is a medical apparel brand based in Austin, Texas, known for its exceptional craftsmanship, luxurious fabrics, and commitment to social and environmental responsibility. Since 2005, Blue Sky has been serving healthcare professionals across the globe with high-quality scrubs and accessories designed for durability, style, and comfort. With a mission rooted in transparency, integrity, and kindness, Blue Sky continues to lead the way in ethical business practices that benefit both people and the planet.

To learn more about Blue Sky Scrubs’ World Oceans Day campaign or to shop the collection, visit www.blueskyscrubs.com.

Media Contact
Company Name: Blue Sky Scrubs
Contact Person: Azu Aguilera
Email: Send Email
Phone: 888-302-5837
Address:2209 Donely Dr.
City: Austin
State: Texas
Country: United States
Website: https://blueskyscrubs.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Blue Sky Scrubs Celebrates World Oceans Day with Commitment to Sustainability and Ocean Conservation

Military Drone Market worth $22.81 Billion in 2030, at a CAGR of 7.6%

“Military Drone Market”
The Military Drone Market is poised to experience growth, advancing from USD 15.80 billion in 2025 to USD 22.81 billion by 2030, with a CAGR of 7.6% from 2025 to 2030.

The report “Military Drone Market by Platform (Small, Tactical, Strategic), Type (Fixed Wing, Rotary Wing, Hybrid), Application (UCAVs, ISR, Delivery), Propulsion (Fuel Powered & Battery Powered), MTOW, Operation Mode, Launching Mode & Region – Global Forecast to 2030” The global military drone market will grow from USD 15.80 billion in 2025 to USD 22.81 billion in 2030 at a CAGR of 7.6% during the forecast period. The military drone market growth is driven by increased investments in advanced military solutions to enhance defense capabilities. The rise in piracy and territorial encroachments in regions like Central Asia, South America, East Africa, the Indian subcontinent, Southeast Asia, and West Africa has led to heightened maritime patrolling and anti-piracy operations. As a result, there is a growing reliance on Unmanned Aerial Vehicles (UAVs) for maritime patrolling and identifying potential hotspots.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221577711

Browse 150 market data Tables and 50 Figures spread through 250 Pages and in-depth TOC on “Military Drone Market”

View detailed Table of Content here https://www.marketsandmarkets.com/Market-Reports/military-drone-market-221577711.html

Based on propulsion, the battery segment is anticipated to record the highest growth rate during the forecast period.

Based on propulsion, the Military Drone Industry has been categorized into turbo engines, piston engines, and battery-powered drones. The battery segment encompasses military drones utilizing lithium-ion batteries, fuel cells, and hybrid cells. During the forecast period, the battery segment is expected to exhibit the highest growth rate at 16.2%, driven by the adoption of batteries in many short- and medium-range and small drones. High-endurance tactical and strategic drones are typically powered by turbo engines, specifically gas-powered turbojet and turbofan engines. Meanwhile, piston engines have found applications in many small military drones designed for low-power and low-speed operations. Battery or electric military drones leverage batteries for energy storage, powering electric motors.

Based on speed, the subsonic segment is estimated to register a significant market share in 2024.

Based on speed, the military drone market is divided into subsonic and supersonic segments. The subsonic is subdivided into drones with speeds of 300 Km/hr. Currently, the subsonic segment dominates the market, reflecting the prevalence of military drones operating at conventional subsonic speeds. Subsonic drones, characterized by speeds ranging from standstill to slightly below the speed of sound (Mach 0.8), contributed significantly to the market share in 2023. This growth is driven by an increased demand for highly autonomous drones operating at high subsonic speeds.

The Asia Pacific region witnessed strong demand for military drones during the forecast period.

The Asia Pacific region stands out as a global leader in technology and innovation, showcasing the fastest growth in military drone adoption. Notably, countries such as China, Malaysia, South Korea, and India are making substantial investments in the development of military drone projects. India frequently procures military solutions from North America and Europe. China, recognized for its advanced technology and efficient manufacturing capabilities, plays a significant role in the drone industry. Key Chinese companies engaged in the manufacturing of military drones, payloads, and drone components include Autel Robotics, China Academy of Aerospace Aerodynamics, Chengdu Rainpoo Technology Co., Ltd., Aviation Industry Corporation of China (AVIC), and China Aerospace Science and Technology Corporation.

Major players in the the Military Drone Companies include Northrop Grumman Corporation (US), Raytheon Technologies Corporation (US), Israel Aerospace Industries Ltd. (Israel), General Atomics Aeronautical Systems (GA-ASI) (US), and Teledyne FLIR LLC (US).

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Delray Beach
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/military-drone-market-221577711.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Military Drone Market worth $22.81 Billion in 2030, at a CAGR of 7.6%

Collagen & Gelatin Market worth US$1,671.3 million in 2030 5.8% CAGR | MarketsandMarkets™

“The report profiles key players such as Integra LifeSciences Corporation (US), Smith+Nephew plc (UK), DSM-Firmenich (Netherlands), Nitta Gelatin Inc. (Japan), Tessenderlo Group (Belgium), Collplant Biotechnologies Ltd. (Israel)”
Browse 280 market data Tables and 53 Figures spread through 252 Pages and in-depth TOC on “Collagen & Gelatin Market by Source (Bovine, Porcine, Marine), Application (Orthopedic, Cardiovascular, Dental, Surgical), Competitive Landscape (Company Profile, Market share, Company Evaluation Matrix), End User, and Region – Global Forecast to 2030

The global Collagen & Gelatin Market, valued at US$1,203.9 million in 2024, is forecasted to grow at a robust CAGR of 5.8%, reaching US$1,295.5 million in 2025 and an impressive US$1,671.3 million by 2030. Growing incidence of diabetes, cancer, and chronic diseases; rising demand for advanced wound care products; surge in surgical procedures; increasing use in tissue engineering and regenerative medicine; extensive application of collagen as a drug delivery system are driving the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122

Browse in-depth TOC on “Collagen & Gelatin Market

228 – Tables

44 – Figures

240 – Pages

By Based on segment, the collagen & gelatin market is divided into bovine, porcine, and others. The large share of the bovine segment can be attributed to the growing adoption of bovine-derived collagen and gelatin in regenerative medicine. Additionally, the increased usage of biomaterials is primarily due to the biocompatibility and biodegradability properties exhibited by these materials.

By Based on application, The collagen market is segmented into orthopaedic, wound care, dental, surgical, cardiovascular, and other applications. In 2024, the orthopaedic application segment accounted for the largest share of the collagen market by applications due to the rising demand for scaffolds and substitutes due to their extensive use in orthopaedic surgeries. This dominance is expected to continue throughout the forecast period due to the rising number of road trauma cases.

By geography, the collagen & gelatin market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2024, North America held the largest share of the collagen & gelatin market, followed by Europe. Asia Pacific registered the highest CAGR growth within the collagen & gelatin market during the forecast period due to its increasing application for research and clinical diagnostics, adoption of collagen & gelatin for transplantation-associated research, and government initiatives and industrial collaboration.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122

The report profiles key players such as Integra LifeSciences Corporation (US), Smith+Nephew plc (UK), DSM-Firmenich (Netherlands), Nitta Gelatin Inc. (Japan), Tessenderlo Group (Belgium), Collplant Biotechnologies Ltd. (Israel), Collagen Solutions plc (UK), Regenity (US), Medtronic plc (Ireland), and Solventum (US).

INTEGRA LIFESCIENCES (US):

Integra LifeSciences leads in the collagen & gelatin market. It operates through two business segments, namely Codman Specialty Surgical and Tissue Technologies. The company offers engineered bovine collagen, bovine dermis, porcine urinary bladder, human amniotic tissue, and resorbable synthetic mesh products through its Tissue Technologies Segment. This segment recorded a decline of 3.3% in 2024 over 2023 due to the impact of the lost revenue related to the Boston product recall, which was partially offset by double-digit growth from BioD and Gentrix and mid-single-digit growth in Integra skin and MediHoney. The company’s leading position is attributable to its diversified product portfolio, geographical expansion, and adoption of organic and inorganic growth strategies. For instance, in March 2024, Integra Life Sciences received an US FDA approval to commercialize a dermal regeneration template for repairing scar contractures.

SMITH+NEPHEW PLC (UK):

Smith+Nephew is one of the leading players in the collagen & gelatin market due to its robust portfolio, including innovative collagen-based scaffolds and collagenase-based enzymatic debridement agents. The company operates through three business segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers collagen and gelatin products through its advanced wound management business segment. Additionally, the company’s strong global presence, strategic partnerships, and commitment to customer-centric solutions position it as a key player in the competitive collagen and gelatin space. The company possesses a strong geographical presence with a broad range of distribution networks to solidify its leadership in the collagen and gelatin market. The advanced wound management business segment of Smith+Nephew has experienced a positive growth rate of 4.7% in the year 2024 and maintained positive momentum in 2024, with growth accelerating toward the end of the year.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/collagen-gelatin-regenerative-medicine-market-95663122.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Collagen & Gelatin Market worth US$1,671.3 million in 2030 5.8% CAGR | MarketsandMarkets™

Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets™

“The report profiles key players such as Charles River Laboratories (US), The Jackson Laboratory (JAX) (US), Taconic Biosciences, Inc. (US), JSR Corporation (US) (Crown Biosciences), Champions Oncology, Inc. (US), CLEA Japan Inc. (Japan)”
Browse 189 market data Tables and 31 Figures spread through 204 Pages and in-depth TOC on “Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models, Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech), and Region – Global Forecast to 2030

The global Humanized Mouse and Rat Model Market, valued at US$255.8 million in 2024, is forecasted to grow at a robust CAGR of 8.2%, reaching US$276.2 million in 2025 and an impressive US$409.8 million by 2030. The surge in the use of humanized models in drug discovery research, rising demand for personalized medicine, and increasing R&D activities in the pharmaceutical & biotechnology industry are contributing to market growth. Additionally, growing demand for humanized mouse models, preference for humanized PDX models, and the emergence of CRISPR in biomedical research are expected to serve as lucrative market opportunities.

The humanized mouse model (hu-mice) is the key segment driving market growth, which is expected to have the largest revenue share in 2024. This segment is dominant due to the advent of genetic engineering technologies such as gene targeting and gene editing. By application, oncology holds the highest market share due to the rising research activities and growing government funding investments to conduct cancer research studies. Additionally, pharmaceutical and biotechnology companies serve as the largest end-user segment due to the unprecedented investments in research and development.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131763955

Browse in-depth TOC on “Humanized Mouse and Rat Model Market

189 – Tables

31 – Figures

204 – Pages

By Based on type, the humanized mouse and rat model market has been segmented into humanized mouse models and humanized rat models. The humanized mouse models’ segment is further divided into genetic humanized mouse models and cell-based humanized mouse models. The genetic models generated the highest revenue in 2024, and this segment is expected to continue this dominance throughout the forecast period. Genetic humanized mouse models have been successfully adopted in analysing biological efficacy, safety testing, pharmaceutical compounds, and studying novel therapeutics. Humanized mouse models are gaining demand in studies around drug metabolism and immune system development & functioning.

By end user, the humanized mouse and rat model market is segmented into pharmaceutical & biotechnology companies, CROs & CDMOs, and academic & research institutes. These organizations procure, maintain, and use humanized mice and rat models to deliver outsourced preclinical research services, particularly in immuno-oncology, cell and gene therapy, and biologics development. CROs serving as direct customers or technical end users of these models are included in this segment. These CROs purchase models from specialized vendors, such as Taconic Biosciences, Inc. (US), The Jackson Laboratory (US), and Hera BioLabs (US), to offer preclinical and clinical research services and generate efficacy, pharmacokinetic (PK/PD), and toxicology data.

By geography, the humanized mouse and rat model market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific market is estimated to register the highest growth during the forecast period. The increase in demand for market products across China and India contributes to this growth. Led by growing R&D activities, the outsourcing of preclinical, clinical, and laboratory testing services for small & large molecules is expected to increase in the country. The expanding pharmaceutical industry, the increasing number of CROs, and the rise in research activities will drive the growth of China’s humanized mouse and rat model market.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=131763955

The report profiles key players such as Charles River Laboratories (US), The Jackson Laboratory (JAX) (US), Taconic Biosciences, Inc. (US), JSR Corporation (US) (Crown Biosciences), Champions Oncology, Inc. (US), CLEA Japan Inc. (Japan), genOway (France), Inotiv (US), Janvier Labs (France), Altogen Labs (US), Vitalstar Biotechnology (China), Ingenious Targeting Laboratory (US), Reaction Biology (US), Harbour BioMed (Netherlands), Oncodesign Services (France), Pharmatest Services (Finland), Ozgene Pty Ltd. (Australia), TransCure bioServices (France), Cyagen Biosciences (US), Aragen Life Sciences Ltd. (India), GemPharmatech (China), and Biocytogen (US), among others.

The Jackson Laboratory (JAX) (US):

is a leading player in the humanized mouse and rat model market. The company has a prominent presence across North America, Europe, and Asia Pacific. The company has built a diverse range of humanized mouse and rat models, strategically focusing on maintaining the existing customer/end-user base and strengthening long-term contracts. It further leverages its position in the ancillary markets, such as drug discovery and disease modeling, to sustain its market position and broaden offerings around the humanized mouse and rat model market.

Charles River Laboratories (US):

is a global drug discovery service CRO that provides a comprehensive portfolio of drug discovery and early-stage development products and services. It has made several acquisitions, partnerships, and cooperation deals. For example, in January 2023, the company acquired SAMDI Tech, which provides label HTS solutions for drug discovery research. In January 2025, it signed a partnership deal with NJ Bio, a CRO providing integrated chemistry and bioconjugation services for developing antibody-drug conjugate (ADC) from concept to clinic. The strategic alliance combines Charles River’s end-to-end ADC discovery services with NJ Bio’s bioconjugation and manufacturing capabilities.

Inotiv (US):

is one of the leading market players in the mice model market. The company’s strength can be attributed to its robust product portfolio and numerous acquisitions & partnerships that allow it to market its products worldwide. Inotiv also has a significant geographical footprint in developed countries across North America and Europe. The company’s revenue grew to USD 490.7 million during the fiscal year 2024 from USD 347.8 million during the fiscal year 2021.

genOway (France)

is a pioneering biotechnology company located in France and is recognized for its capabilities in developing genetically engineered mouse and rat models for biomedical research. genOway’s commitment to innovation and quality has made it an attractive partner for pharmaceutical companies, biotechnology companies, and academic centers globally.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/humanized-mouse-model-market-131763955.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Humanized Mouse and Rat Model Market worth US$409.8 million in 2030 with 8.2% CAGR | MarketsandMarkets™

Biopsy Devices Market worth US$11.01 billion by 2030 with 7.2% CAGR | MarketsandMarkets™

“The north America accounts for the largest market share of 32.9% in the biopsy device market. North America leads the market for biopsy devices. This is due to its well-developed healthcare system, high healthcare expenditure, and key players strong base in the market. The region has rising incidence rates of cancer.”
Browse 717 market data Tables and 60 Figures spread through 503 Pages and in-depth TOC on “Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) – Global Forecast to 2030

The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching US$7.27 billion in 2024 and an impressive US$11.01 billion by 2030. The rising prevalence of cancer. Additionally, the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies are likely to promote the growth of biopsy device market. Underdeveloped healthcare infrastructure in emerging economies would challenge the growth of the biopsy device market across the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132886515

Browse in-depth TOC on “Biopsy Devices Market

170 – Tables

70 – Figures

300 – Pages

By product type, the biopsy devices market is divided into Needle based biopsy instrument, Visualization device, Brush biopsy instrument, Biopsy accessory and robotic biopsy device. Among these, in 2023, the biopsy accessory segment accounted for the second highest market share in the biopsy device market. These accessories, such as needles, forceps, and localization wires, are important for ensuring proper sample collection, accuracy, and procedural effectiveness. The rising incidence of cancer and the growing use of image-guided biopsy methods have fueled the demand for quality accessories. This maximizes the diagnostic accuracy. Moreover, ongoing technological innovations, such as the creation of disposable and minimally invasive biopsy accessories, have also accelerated market growth. Their extensive use throughout hospitals, diagnostic laboratories, and ambulatory surgery centers, and the requirement of successive use in several procedures, guarantees consistent demand, making their firm position in the market.

By end-user, the biopsy devices market is segmented into hospitals and breast care centers, diagnostic imaging centers, ambulatory surgical centers and other end users. In 2023, The hospitals and breast care centers segment accounted for the largest share of the biopsy devices market. These centers are well equipped with the latest imaging modalities like MRI, ultrasound, and mammography. This would facilitate accurate image-guided biopsies. Also, hospitals and specialty breast care centers are the main sites of care for cancer screening programs, especially for breast cancer, which is one of the most prevalent cancers globally. Rising cases of breast cancer, along with government support for early diagnosis, have increased the demand for biopsy procedures in such hospitals. Also, hospitals are associated with research institutions and diagnostic laboratories thus, making it possible to have access to cutting-edge biopsy technologies like liquid biopsy and molecular diagnostics. In addition to that, Insurance coverage and reimbursement policy are also helping increase the volumes of biopsy procedures in such hospitals.

By geography, the biopsy devices market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa. The north America accounts for the largest market share of 32.9% in the biopsy device market in 2023. North America leads the market for biopsy devices. This is due to its well-developed healthcare system, high healthcare expenditure, and key players strong base in the market. The region has rising incidence rates of cancer. Further, with consequent high demand for advanced biopsy procedures and favorable reimbursement policies foster the adoption of biopsy devices. Technological advancements such as AI-based biopsy systems further increase the growth of the market. Additionally, government policies supporting cancer research and early diagnosis schemes, along with an increasing number of elderly people prone to chronic diseases, also support the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515

Prominent players in the biopsy device market include, BD (US), Devicor medical products, Inc (US), Medtronic (Ireland), Cardinal Health (US), B. Braun SE (Germany), Hologic, Inc. (US), Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Corporation (Japan), Stryker (US), Teleflex Incorporated (US), CONMED Corporation (US), Merit Medical Systems (US), Johnson & Johnson Services, Inc. (US), Cook Group (US), MicroPort Scientific Corporation (China), Argon Medical Devices (US), INRAD, Inc (US), Summit Medical LLC (US), TransMed7, LLC (US), Dr. Japan Co., Ltd. (Japan), IZI Medical Products (US), Planmed Oy (Finland), Advin Health Care (India), Trivitron Healthcare (India).

Devicor Medical Products, Inc. (US):

Devicor Medical Products has the largest market share in the biopsy devices market largely because of its highly innovative and popular Mammotome® biopsy system. The system is a top VAB technology with high accuracy and low invasiveness, which has emerged as the go-to method for the diagnosis of breast cancer. Devicor has a very well-established brand reputation, rigid global distribution channels, and strategic partnerships with healthcare professionals, guaranteeing its popularity among the stake holders and broad use of its products. The company is also involved in extensive investments in research and development, constantly improving the efficiency of biopsy devices. Its wide-ranging portfolio, that comprises of disposable biopsy needles and ultrasound-guided systems, addresses varied clinical requirements, reinforcing its strong leadership in the biopsy devices market.

Medtronic (Ireland):

Medtronic has a strong competitive advantage in the market for biopsy devices due to its minimally invasive biopsy solutions and strong research and development capabilities. For example, Medtronic produces sophisticated biopsy devices such as robotic biopsy devices developed to make the biopsy process more accurate and also increase patient comfort. The company’s global reach, acquisitions, and partnerships with stakeholders also help cement its place in the industry. Being one of the leading players in the Biopsy Devices market, Medtronic has also established itself through an established network of distributors and continues to invest in the creation of new technologies, thus catering to the increasing requirement of early diagnostics and minimally invasive treatment of diseases.

Cardinal Health (US):

Cardinal Health with its large product line, robust distribution network, and strategic purchases, makes it a leader in biopsy devices market. Cardinal Health provides a broad selection of high-quality biopsy devices to address multiple clinical requirements in oncology and pathology. Its worldwide distribution chain and robust logistics infrastructure also provide it with the broad accessibility of biopsy instruments. This enhances its market dominance. Further, Cardinal Health has exploited strategic alliances and acquisitions to grow its product and technological strength base, enabling it to effectively rival market leaders in the industry.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biopsy-device-market-132886515.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biopsy Devices Market worth US$11.01 billion by 2030 with 7.2% CAGR | MarketsandMarkets™

Ariana Designs & Interiors Unveils 13,500-Square-Foot Luxury Suncadia Retreat

Full-service Pacific Northwest design firm completes multi-year architectural and interior project in Cle Elum, WA

BELLEVUE, WA – June 5, 2025 – Ariana Designs & Interiors, a full-service design-build firm based in Bellevue, WA, announces the successful completion of a four-year luxury home design project in Suncadia, Washington. The 13,500-square-foot custom vacation home was designed to host multigenerational gatherings and stands as a testament to the firm’s integrated expertise in architecture and interiors.

The speakeasy-style lounge offers an immersive, elevated experience designed for evening gatherings and late-night conversations.

A Showcase of Intentional Pacific Northwest Design

Situated in the forested resort community of Suncadia, this bespoke residence merges elegance with functionality. Ariana Designs & Interiors completed the project’s unique design, crafting architectural layouts and fully curated interiors to meet the owners’ exact vision. The firm, known for its Pacific Northwest design philosophy, emphasized seamless transitions between communal gathering areas and private retreats, establishing a fluid balance ideal for extended family living.

“This project represents the core of what we do, bringing our clients’ vision to life through intentional, collaborative design,” said Ariana Anderson, CEO of Ariana Designs & Interiors. “From the floor plan to the finishes, every detail was selected with purpose, designed to support the lifestyle and values of the family who will enjoy this home for generations.”

Bespoke Entertainment Meets Luxury Interiors

At the center of the Suncadia retreat is a one-of-a-kind speakeasy-inspired entertainment suite, tailored for memorable moments. Complete with a full bar, poker room, shuffleboard, ping pong, and pool tables, the space was designed to deliver visual impact while maintaining practical usability. This hallmark feature illustrates the firm’s commitment to blending lifestyle with luxury interiors.

Renowned across Kirkland interior design and Bellevue home renovation markets, Ariana Designs & Interiors continues to push boundaries in boutique interior design Seattle projects and beyond. The Suncadia home also incorporates spa-style bathrooms, refined private suites, and high-efficiency kitchen layouts, all constructed with precision and elegance.

Integrated Full-Service Design-Build Capabilities

As a full-service design firm Seattle homeowners trust, Ariana Designs & Interiors handles every phase from initial architectural planning to final furnishing in Redmond to Mercer Island design-build, and custom homes in Clyde Hill, the team applies its expertise to a wide range of Pacific Northwest luxury homes.

This custom vacation home design showcases how thoughtful collaboration between architectural and interior disciplines can deliver elevated living spaces catering to daily use and extended hosting.

Building the Future of Washington Vacation Home Design

With a growing portfolio that includes Medina estate interiors, designer homes in Cle Elum, and celebrated as a top architectural designer in Bellevue, Ariana Designs & Interiors is reinforcing its position as a leader in luxury design-build Washington projects. This Suncadia retreat exemplifies the firm’s commitment to sophisticated, site-specific solutions rooted in client lifestyle and regional aesthetics.

To learn more about this project or explore additional work, visit: https://ariid.com/portfolio/suncadia-home

About Ariana Designs & Interiors

Ariana Designs & Interiors is a Kirkland, WA-based design firm offering full-service architectural and interior design solutions. Specializing in high-end residential projects, the firm delivers cohesive, client-driven environments from boutique interior renovations to expansive custom vacation homes throughout the Pacific Northwest.

Media Contact
Company Name: Ariana Designs & Interiors
Contact Person: Ariana Anderson
Email: Send Email
Phone: 425-679-2463
Country: United States
Website: https://ariid.com/

Griggs Publishing Announces Artificial Intelligence (AI) Guide to Create Films, Automating Many Steps in the Production Process

Griggs Publishing Announces Artificial Intelligence (AI) Guide to Create Films, Automating Many Steps in the Production Process

Damian Griggs, CEO of Griggs Publishing
Filmmakers can now use AI to make a complete movie a little at a time with “Al Film Production: A Simplified Guide”

PORTLAND, Ore. – June 5, 2025 – Griggs Publishing today announced the introduction of its groundbreaking AI film-creation pipeline guide, designed for new and experienced filmmakers to create a movie in incremental steps. The company’s “Al Film Production: A Simplified Guide” implements artificial intelligence (AI) to facilitate film-making through small, incremental steps. This process stands in contrast to the traditional need to stay on a timeline and budget to make a film all at once. The AI helps create the film through short segments using 2-minute videos. These segments are then combined to make an entire movie.

“AI innovation is incredibly helpful with continuity,” said Damian Griggs CEO of Griggs Publishing. “The challenge is to keep everything consistent, including characters, backgrounds, style, and sound, so the scenes look and feel the same from one segment to the next. The AI reads your screenplay to find scenes, characters, dialogue, and stage directions. AI also assists the filmmaker with the movie’s look through its scene visual generation module.”

The AI automated film pipeline assembles films out of the segments, in what Griggs Publishing characterizes as “a semi-consistent method to create proofs of concepts for films.” AI organizes all parts of a movie, offering tools that organize a digital list in the form of a JSON file that breaks down a script into details for each small video scene or segment and a voice generation module which gives characters a voice, converting written dialog from a script into spoken audio, using character voices.

Additional groundbreaking tools from Griggs include AI application programming interface (API) services like ElevenLabs, Bark, XTTS, or OpenTTS, which are “messengers” that let the filmmaker use these specialized voice-making tools.

For more information and interview requests, visit:

https://griggspublishingllc.com/

And email:

griggspublishing@griggspublishing.com

Media Contact
Company Name: Griggs Publishing
Contact Person: Damian Griggs
Email: Send Email
Country: United States
Website: https://griggspublishingllc.com/

Global Hair Serum Market Report 2021-2030: L’Oréal Group, Henkel Ag & Co. KGaA, Kao Corporation, and Unilever are the Major Stakeholders – Focus Report Store

“Global Hair Serum Market Research Report by Arizton”
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030.

According to Focus Report Store, the global hair serum market growing at a CAGR of 8.95% during 2024-2030.

 

Looking for More Information? Click: https://www.focusreports.store/report/hair-serum-market

 

Report Scope:

Market Size (2030): USD 2.63 Billion

Market Size (2024): USD 1.57 Billion

CAGR (2024-2030): 8.95%

Historic Year: 2021-2023

Base Year:2024

Forecast Year: 2025-2030

Largest Region (2024): Asia Pacific

Market Segmentation: Ingredients, Consumers, Applications, Distribution Channel, And Geography

Geographic Analysis: North America, Europe, APAC, Latin America, And The Middle East & Africa

 

The global hair serum market is evolving rapidly, driven by the discoveries and developments of advanced and unique active ingredients, growing awareness of hair serum and associated benefits, rising spending on beauty and personal care approaches, and growing application of internet and social media platforms creating awareness about hair serum and associated clinical benefits led to drive the market growth.

Furthermore, major market players are now prioritizing e-commerce platforms for the sale of their hair serum products. However, drug stores/pharmacies remain the dominant distribution channel as there is an increase in hair concerns. Several market players heavily invest in R&D to develop innovative and efficient hair serum products. High R&D spending, coupled with product innovation, will aid market growth over the coming years

 

Recent Market Activities

  • In 2025, Unilever (Hindustan Unilever Limited) developed the advanced Dove Scalp + Hair Therapy Density Boost hair serum that combination of Zinc-peptide and niacinamide to grow over 10,000 new hair strands in eight weeks of use.
  • In 2023, Ivachi, a personal care brand launched a range of haircare product lines including hair serum – Hair Booster Serum to reduce hair fall and trigger hair growth.
  • In 2022, Briogo launched Destined for Destiny Peptide Hair Serum with a unique proposition for thicker and fuller hairs.

 

Clinically-Effective Hair Serums Gain Traction Amid Demand for Science-Driven Beauty Solutions

The hair care industry is experiencing a shift as consumers grow increasingly conscious about the efficacy of personal care products. Hair serums, once positioned primarily as styling aids, are now emerging as multifunctional treatments offering both cosmetic appeal and clinically proven benefits. With rising awareness, consumers are actively seeking solutions that address deeper concerns such as hair fall, scalp health, and nourishment, beyond just frizz control.

Further supporting this evolution, Inde Wild’s 2024 blog highlights that next-gen serums now incorporate clinically studied ingredients like Redensyl, Procapil, Caffeine, Baicapil, Moringa, and Biotin, all known to stimulate hair follicles, reduce breakage, and promote regrowth. Additionally, natural actives such as rosemary extract, rice water, argan oil, and vitamin E are being recognized for their reparative properties, strengthening hair shafts, boosting shine, and improving vitality. As the demand for evidence-based, clean-label beauty products continues to grow, hair serum brands embracing clinically effective, ingredient-forward formulations are well-positioned to capture attention from both consumers and investors.

 

E-commerce Revolutionizing Hair Serum Accessibility

The hair serum industry is experiencing unprecedented growth, largely fueled by the rapid adoption of e-commerce across both developed and developing markets. With a significant shift in consumer purchasing behavior from traditional in-store buying to online platforms, e-commerce has emerged as a pivotal channel for product discovery and purchase. This transformation was further accelerated during the COVID-19 pandemic, as digital platforms became essential for product access and brand engagement. Hair care brands, recognizing this shift, have actively partnered with both global and regional e-commerce platforms to expand their market reach and connect with individual consumers at scale.

Innovative technologies such as Augmented Reality (AR) are now being leveraged within online retail environments, enabling users to virtually try on hair serum products and preview potential results—enhancing confidence and increasing conversion rates. Companies like Ulta Beauty, Inc. have acknowledged the vital role of e-commerce in boosting sales across their hair care portfolio, emphasizing that heightened competition in digital spaces is carving new opportunities for product visibility and consumer engagement. Similarly, Kaya, a prominent player in the hair serum segment, has strengthened its e-commerce footprint since 2022, forging strong partnerships with leading platforms across the APAC region to drive sales and brand recognition in the evolving digital marketplace.

 

APAC Emerges as Key Region for Hair Serum Innovation and Demand

Asia Pacific (APAC) dominates the hair serum market with the largest share of over 45% and shows the highest growth during the forecast period. APAC is one of the major regions for hair care product consumption and is expected to witness lucrative revenue growth opportunities in the future. Consumers in APAC place greater emphasis on natural ingredients that promote hair health, compared to other regions. This preference is driving the adoption of advanced hair serum solutions. China and India are the two largest markets for hair serums in the region. The presence of a large potential consumer base, along with high awareness about hair care products, is propelling significant market growth in these countries.

Within APAC, China, India, Japan, and South Korea are key countries experiencing rapid transformation in personal care routines. South Korea, in particular, is renowned for its K-beauty practices, which are influencing grooming habits across the region. The growing usage of hair serums throughout APAC represents a strong opportunity for future revenue growth.

 

Looking for More Information? Click: https://www.focusreports.store/report/hair-serum-market

 

Key Vendors

  • L’Oréal Groupe
  • Henkel Ag & Co. KGaA
  • Kao Corporation
  • Unilever

Other Prominent Vendors

  • Amka Products
  • Avon
  • Slicks Organic Private Limited (ARATA)
  • Avimee Herbal
  • Anveya
  • Bajaj Consumer Care
  • Dabur International
  • Divi Official
  • Giovanni Cosmetics
  • HERSTYLER
  • Hims & Hers Health
  • IVACHI Premier Care
  • John Paul Mitchell System
  • Jstor House of Cosmetics
  • Kaya Skin Clinic
  • Lassnatural
  • Marico
  • mamaearth
  • OLAPLEX
  • Pink Root
  • PURA D’OR
  • Revlon
  • Redken
  • WISHCARE
  • Wella Operations US LLC,

Market Segmentation & Forecasts

Ingredients

  • Conventional Ingredients
  • Organic Ingredients

Consumers

  • Women
  • Men

Application

  • Treatment
  • Aesthetics

Distribution Channels

  • Offline
  • Online

By Geography

APAC

  • China
  • India
  • Japan
  • South Korea
  • Australia

Europe

  • Germany
  • France
  • Spain
  • UK
  • Italy

North America

  • US
  • Canada

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Turkey
  • Saudi Arabia
  • South Africa

 

Other Related Reports that Might be of Your Business Requirement

U.S. Hair Care Market – Focused Insights 2024-2029

https://www.focusreports.store/report/united-states-hair-care-market

Global Hair Wigs And Extension Market – Focused Insights 2024-2029

https://www.focusreports.store/report/hair-wigs-and-extension-market-focused-insights

 

What Key Findings Will Our Research Analysis Reveal?   

  • How big is the global hair serum market?
  • What is the growth rate of the global hair serum market?
  • Which type of hair serum product will dominate the market growth?
  • Which region dominates the global hair serum market?
  • What are the factors driving the global hair serum market growth?

 

Why Arizton?       

100% Customer Satisfaction       

24×7 availability – we are always there when you need us       

200+ Fortune 500 Companies trust Arizton’s report       

80% of our reports are exclusive and first in the industry       

100% more data and analysis       

1500+ reports published till date       

       

Post-Purchase Benefit       

  • 1hr of free analyst discussion       
  • 10% off on customization       

       

About Us:       

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.       

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.       

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.       

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.focusreports.store/report/hair-serum-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Global Hair Serum Market Report 2021-2030: L’Oréal Group, Henkel Ag & Co. KGaA, Kao Corporation, and Unilever are the Major Stakeholders – Focus Report Store

Graves Disease Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Therapies, Statistics, Revenue, Prevalence, and Companies by DelveInsight

“Graves Disease Drugs Market”
Graves’ Disease Companies are Immunovant Sciences GmbH, Novartis Pharmaceuticals, Apitope International NV, AV7 Limited, Medtronic, Pfizer, Sanguine Biosciences, Tourmaline Bio Inc., Horizon Pharma USA Inc., Quintiles Inc., European Commission, Viridian Therapeutics Inc., Innovent Biologics Co. Ltd, Hoffmann-La Roche and others.

(Albany, USA) DelveInsight’s “Graves’ Disease Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Graves’ Disease Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Graves’ Disease Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.

The Graves’ Disease market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Graves’ Disease market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Graves’ Disease treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Graves’ Disease market.

 

Unlock detailed insights into the Graves’ Disease Market by downloading the comprehensive report from DelveInsight @ Graves’ Disease Treatment Market Size

 

Key Takeaways from the Graves’ Disease Market Report

  • In May 2025, Immunovant Sciences GmbH announced results of a Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves’ Disease
  • In May 2025, Biohaven Pharmaceuticals, Inc announced results of an Open-Label Biomarker Study of BHV-1300 in Graves’ Disease
  • In January 2025, Sling Therapeutics, Inc., a late-stage biopharmaceutical company developing an oral small molecule therapy for thyroid eye disease, announced topline results on the efficacy and safety of linsitinib from the Phase IIb/III LIDS trial in patients with active, moderate to severe TED.
  • In September 2024:- Immunovant Sciences GmbH- A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants With Active Thyroid Eye Disease (TED). To evaluate the efficacy of batoclimab 680 milligrams (mg) subcutaneous (SC) once a week (QW) for 12 weeks followed by 340 mg SC QW for 12 weeks versus placebo on proptosis responder rate at Week 24.
  • In September 2024:- Amgen- The study consists of a randomized double-masked, placebo-controlled, parallel-group, multicenter trial with an optional open-label treatment period for proptosis non-responders who complete the Double-masked Treatment Period. The main objective of the study is to evaluate the effect of teprotumumab subcutaneous administration versus placebo on the proptosis responder rate (ie, the percentage of participants with a ≥ 2-mm reduction from Baseline in the study eye without deterioration [≥ 2-mm increase] of proptosis in the fellow eye) at Week 24.
  • As per DelveInsight’s estimates, Graves’ disease is the primary cause of hyperthyroidism, responsible for 60–80% of cases. Despite this prevalence, it is relatively uncommon, impacting roughly 1.2% of the US population.
  • According to American Thyroid Association (2024), more than 12% of the US population will develop a thyroid condition during their lifetime and an estimated 20 million Americans have some form of thyroid disease. Women are five to eight times more likely than men to have thyroid problems.
  • As per data from the National Institute of Diabetes and Digestive and Kidney Diseases (2021), Graves’ disease affects nearly 1 in 100 Americans.
  • According to Shang et al. (2024), an estimated 2.7–3.0% of the adult Chinese population—over 31 million individuals—are affected by one or more autoimmune diseases, a prevalence comparable to that seen in Western populations. The predominant contributors to this burden are autoimmune thyroid diseases and rheumatoid arthritis.
  • The leading Graves’ Disease Companies such as Apitope International NV, Quintiles Inc., European Commission, Immunovant Sciences GmbH, Novartis Pharmaceuticals, AV7 Limited, Medtronic, Pfizer, Sanguine Biosciences, Tourmaline Bio Inc., Horizon Pharma USA Inc., Viridian Therapeutics Inc., Innovent Biologics Co. Ltd, Hoffmann-La Roche and others.
  • Promising Graves’ Disease Therapies such as linsitinib, Batoclimab, Teprotumumab, VRDN-001 10 mg/kg, Satralizumab, IBI311, and others.

 

Gain a competitive edge in the Graves’ Disease Market by exploring our in-depth analysis. Visit our website to access the full report and make informed strategic decisions @ Graves’ Disease Treatment Drugs

 

Graves’ Disease Epidemiology Segmentation in the 7MM

  • Graves’ Disease Gender-specific Cases
  • Total Graves’ Disease Prevalent Cases
  • Graves’ Disease Age Group-specific Cases
  • Total Graves’ Disease Treated Cases

 

Graves’ Disease Market Insights

Graves’ disease, an autoimmune disorder and the leading cause of hyperthyroidism, characterized by symptoms such as weight loss, rapid heartbeat, and in some cases, thyroid eye disease. While traditional treatments like anti-thyroid medications, radioactive iodine therapy, and thyroidectomy remain the cornerstone of management. Anti-thyroid drugs, such as methimazole and propylthiouracil (PTU), are commonly used to suppress thyroid hormone production, with Methimazole being the preferred first-line therapy due to its efficacy and safety profile. Radioactive iodine therapy is favored in the United States, especially when drug therapy is ineffective or contraindicated. It induces hypothyroidism, requiring thyroid hormone replacement. However, it is not recommended for patients with Graves’ ophthalmopathy or smokers due to potential risks.

 

Discover key developments and opportunities in the Graves’ Disease Market. Click here to learn more from DelveInsight’s latest report @ Graves’ Disease Market Size

 

Graves’ Disease Treatment Market

The DelveInsight’s Graves’ Disease treatment market report gives a thorough understanding of Graves’ Disease by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment. The Graves’ Disease treatment market has experienced significant growth and evolution in recent years, reflecting the increasing prevalence of Graves’ disease, an autoimmune disorder that affects the thyroid gland. The Graves’ Disease treatment market has witnessed the advent of innovative treatment modalities, including anti-thyroid drugs, radioactive iodine therapy, and surgery

 

Graves’ Disease Companies and Therapies

  • Sling Therapeutics, Inc.: linsitinib
  • Immunovant Sciences GmbH: Batoclimab
  • Amgen: Teprotumumab
  • Viridian Therapeutics Inc.:- VRDN-001 10 mg/kg
  • Hoffmann-La Roche: Satralizumab

 

Download DelveInsight’s Graves’ Disease Market report today and stay ahead in this rapidly evolving field. @ Graves’ Disease Clinical Trials and FDA Approvals

 

Scope of the Graves’ Disease Market Report

  • Coverage- 7MM
  • Graves’ Disease Companies- Apitope International NV, Quintiles Inc., European Commission, Immunovant Sciences GmbH, Novartis Pharmaceuticals (SWX: NOVN), AV7 Limited, Medtronic (NYSE: MDT), Pfizer (NYSE: PFE), Sanguine Biosciences, Tourmaline Bio Inc. (NASDAQ: TRML), Horizon Pharma USA Inc., Viridian Therapeutics Inc. (NASDAQ: VRDN), Innovent Biologics Co. Ltd (HKEX: 1801), Hoffmann-La Roche (SWX: RO), and others.
  • Graves’ Disease Therapies- linsitinib, Batoclimab, Teprotumumab, VRDN-001 10 mg/kg, Satralizumab, IBI311, and others.
  • Graves’ Disease Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Graves’ Disease Unmet Needs, KOL’s views, Analyst’s views, Graves’ Disease Market Access and Reimbursement

 

Download the report to understand which factors are driving Graves’ Disease Market Dynamics @ Graves’ Disease Market Trends

 

Table of Content

1. Key Insights

2. Graves’ Disease Executive Summary

3. Competitive Intelligence Analysis for Graves’ Disease

4. Graves’ Disease: Market Overview at a Glance

5. Graves’ Disease: Disease Background and Overview

6. Patient Journey

7. Graves’ Disease Epidemiology and Patient Population

8. Graves’ Disease Treatment Algorithm, Current Treatment, and Medical Practices

9. Graves’ Disease Unmet Needs

10. Key Endpoints of Graves’ Disease Treatment

11. Graves’ Disease Marketed Products

12. Graves’ Disease Emerging Therapies

13. Graves’ Disease: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Graves’ Disease Market Outlook

16. Graves’ Disease Market Access and Reimbursement Overview

17. Graves’ Disease KOL Views

18. Graves’ Disease Market Drivers

19. Graves’ Disease Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Graves Disease Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Therapies, Statistics, Revenue, Prevalence, and Companies by DelveInsight

Power Metallic (TSX.V: PNPN) (OTCQB: PNPNF) Strikes Big at Lion Zone – Major Discovery Near Nisk Ignites Investor Buzz – More Stocks Inside

Power Metallic Mines Inc. (TSX.V: PNPN) (OTCQB: PNPNF) has announced high-grade results from its Winter 2025 drill program, including a standout intercept of 12.54 meters at 10.99% CuEq from hole PML-25-012a at the Lion Zone. The interval includes 3.10 g/t gold, 25.52 g/t silver, 4.09% copper, 12.06 g/t palladium, and 2.00 g/t platinum.

At Nisk East, hole PMN-25-004 returned 11.25 meters at 1.22% CuEq, including copper, silver, nickel, and palladium. Significantly, this marks the first “Lion-like” mineralization near the Nisk Zone, suggesting broader mineral continuity across the project. The results will support Power Metallic’s upcoming mineral resource estimate for the high-grade Quebec project. For full details, see the company’s official release.

In addition to Power Metallic Mines Inc.’s, (TSXV: PNPN) (OTCQB: PNPNF)momentum keep an eye on: Ryvyl Inc. (NASDAQ: RVYL), MKDWELL Tech Inc. (NASDAQ: MKDW), ATIF Holdings Ltd (NASDAQ: ZBAI), Senmiao Technology Ltd (NASDAQ: AIHS), Cheetah Net Supply Chain (NASDAQ: CTNT), Planet Labs (NYSE: PL), Treasure Global Inc. (NASDAQ: TGL) and Liminatus Pharma Inc. (NASDAQ: LIMN) as they are moving aggressively in early trading today.

Power Metallic Mines Inc. (TSX.V: PNPN) (OTCQB: PNPNF) believes these results validate its evolving exploration model and strongly support future resource growth. The Lion Zone continues to emerge as a high-grade, polymetallic system rich in copper, nickel, palladium, platinum, silver, and gold—all of which are critical to electric vehicles, clean energy, and global electrification supply chains.

“These results not only reinforce the exceptional grade and metal diversity of the Lion Zone, but also mark the first confirmed Lion-like hit near the Nisk Zone,” said the company’s management. “This expands the potential for a multi-zone, high-grade corridor across our Quebec project.” The drilling data will be incorporated into Power Metallic’s ongoing geological modeling to support an upcoming mineral resource estimate, and guide future exploration across the Nisk trend.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Power Metallic (TSX.V: PNPN) (OTCQB: PNPNF) Strikes Big at Lion Zone – Major Discovery Near Nisk Ignites Investor Buzz – More Stocks Inside